Emphasis
The emphasis is on development of transformative machine intelligence-based systems, emerging tools, and modern technologies for diagnosing and recommending treatments for a range of diseases and health conditions. Unsupervised and semi-supervised techniques and methodologies are of particular interest.
Program priorities and areas of interest:
- clinical decision support systems
- computer-aided diagnosis
- computer-aided screening
- analyzing complex patterns and images
- screening for diseases
- natural-language processing and understanding
- medical decision-making
- predictive modeling
- computer vision
- robotic and image guided surgery
- personalized imaging and treatment
- drug discovery
- radiomics
- machine/deep learning-based segmentation, registration, etc.
Additional support
This program also supports:
- early-stage development of software, tools, and reusable convolutional neural networks
- data reduction, denoising, improving performance (health-promoting apps), and deep-learning based direct image reconstruction
- approaches that facilitate interoperability among annotations used in image training databases
Related News
A new gene editing tool that helps cellular machinery skip parts of genes responsible for diseases has been applied to reduce the formation of amyloid-beta plaque precursors in a mouse model of Alzheimer’s disease, researchers at the University of Illinois Urbana-Champaign report. Source: University of Illinois Urbana-Champaign News Bureau
With the help of some of nature’s best engineers, NIBIB-funded researchers have developed technology to regrow damaged facial nerves.
Massachusetts Institute of Technology (MIT) engineers developed AI frameworks to identify evidence-driven hypotheses that could advance biologically inspired materials. Source: MIT News
Releasing a drug selectively in specific locations in the body, including the brain, has been challenging. Researchers at the University of Utah have tackled the problem by designing ultrasound-sensitive nanoparticles that release a drug at the targeted site when activated by focused ultrasound.
NIH has awarded more than $4 million in funds and support services to three diagnostic technology developers as part of RADx ® Tech’s Advanced Platforms for HIV Viral Load Monitoring program.